Search

Navigate evaluated the impact of an online resource for men with low-risk prostate cancer when making a treatment decision, and to assess the uptake of Active Surveillance; satisfaction with treatment decision, decisional... Read more

Our research has found that a lot of information is provided to patients at their hospital appointments, and this can be confusing and overwhelming, especially if people are feeling anxious, upset, or have been given some... Read more

The Industry and commercialisation team supports researchers with intellectual property identification, evaluation and protection. They also advance industry engagement, collaborative and contract research services, and... Read more

Technologies available for partnering or licensing  Circulating tumour DNA for monitoring disease burden and genomic changes in cancer  SwitchCAR; converts TGFβ signalling into immunostimulation in CAR-T cell... Read more

Immuno-oncology networks  Bristol-Myers Squibb II-ON – International Immuno-Oncology Network  We are the first Australian institute to be added to BMS II-ON. II-ON is an international network of leading... Read more

For further information on any of these resources, please contact the TTO who can link you with the relevant program. We can point you in the right direction if you are unsure. Read more